Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
10,766 total articles
Roche is pushing into obesity with CT-388 after a strong Phase 2 update, and the stock is breaking to fresh 52-week highs. The trade idea is to buy the pullback or controlled breakout, targeting a move into the low $60s while using a tight stop below trend support. The setup leans on bullish momentum, expanding attention on CT-388, and a market tha…
Seritage Growth Properties (SRG) trades like a liquidation vehicle with heavy short interest and thin liquidity. With the market focusing on past control/valuation headlines, incremental positives like term-loan debt reduction after the Aventura sale can matter disproportionately. Technically SRG is sitting below key moving averages with RSI in the…
MercadoLibre has pushed back toward the top of its 52-week range as momentum turns bullish, yet the stock still screens reasonably priced for a business with entrenched e-commerce scale and a fast-growing fintech ecosystem. With strong technicals, manageable short interest, and valuation metrics that aren’t stretched relative to quality, MELI offer…
Avita Medical (RCEL) is attempting a turnaround after a steep drawdown into early January. The stock has reclaimed key moving averages with bullish MACD momentum, while short interest remains elevated with roughly two weeks of days-to-cover. Recent symposium data added constructive narrative support around RECELL outcomes and health economics. This…
IonQ has turned into a headline-driven quantum proxy, and the latest wave of “national priority” framing around quantum plus IonQ’s aggressive M&A push is keeping buyers engaged even as the chart has cooled off. With the stock sitting below key moving averages, RSI in the low-40s, and short interest still elevated, the risk-reward favors a defined …
Rekor Systems is trading near $1.25 with an oversold tape (RSI ~29) and bearish momentum, yet the fundamental story is not standing still: Q3 2025 revenue hit a record $14.2M (+35% YoY) and the company highlighted a $50M Georgia DOT contract. With short interest still elevated and the stock far below its $3.42 52-week high, the setup favors a defin…
Pure Cycle has quietly stacked profitable quarters and just printed a sharp revenue step-up, while the stock grinds higher with bullish momentum signals. With a clean balance sheet and a business model tied to long-duration Colorado development, PCYO offers a tradable breakout/retest setup near $12 with a tight stop and a defined catalyst window.
Geron has spent the last year getting punished for a messier-than-hoped commercial ramp, and the stock price shows it. But at roughly a $0.88B market cap and ~$1.39/share, the setup is starting to look asymmetrical: the company is actively cutting costs (12/11/2025 restructuring), liquidity ratios are strong (current ~5.93, quick ~4.85), and short …
Toll Brothers has pulled back from fresh 52-week highs even as profitability and balance-sheet metrics remain solid for a cyclical builder. With TOL trading around $143 and roughly 10x earnings, the market is already pricing in a softer housing backdrop. This trade idea looks for a mid-term rebound toward the prior high while defining risk below re…
TSMC is back in a constructive technical and valuation posture after a reset from its recent highs. With price above key moving averages, RSI still supportive, and the market continuing to treat TSM as an AI infrastructure gatekeeper, the risk-reward now favors a buy with a defined stop below broken support. Catalysts include continued AI-driven ca…
Kornit Digital sells industrial digital printing systems and inks that let apparel brands and producers print on demand with less waste and faster turnaround. The stock is depressed near $13, well below the $30.24 52-week high, with momentum still bearish and RSI washed out. This sets up a mid-term rebound trade if $11.93 holds and price can reclai…
Waste Management has been grinding higher with strong technical momentum, and the fundamental setup looks better than the market’s recent “growth pause” narrative. As volume headwinds fade, WM’s pricing strength and margin discipline can reassert a steadier growth profile. With buybacks and a rising dividend in the backdrop, this is a mid-term brea…
Stellantis has spent the past year grinding lower, but at roughly $9.78 the stock is starting to look like it’s pricing in a lot of pain. Technically, STLA is oversold (RSI ~38) and stretched below key moving averages, while short interest remains meaningful with days-to-cover near 5.7. Fundamentally, the market is valuing the company at about $36.…
Mattel is trading below its early-January highs with momentum washed out, while valuation remains undemanding for a company that’s increasingly treated as an IP and licensing platform, not just a toy seller. The trade: buy weakness near current levels with defined risk, looking for a move back toward the 52-week highs and beyond as 2026 expectation…
TSMC sits at the center of America’s AI infrastructure rush, and the tape is still bullish. But with TSM near its 52-week high and trading around 31x earnings with a lofty ~10.5x book, the market is treating durable AI demand as a certainty. This trade idea leans short over a 45-trading-day window, looking for a valuation reset or simply a cooling-…
Lumentum (LITE) is ripping higher as investors re-rate optical and photonic components tied to AI data center buildouts. The stock is pressing into the low $370s after a huge multi-month run, and the setup is now about whether momentum can carry it back toward the $400 area ahead of the next major catalyst: earnings on 02/03/2026. This is an action…
SEMHF is trading around $52.38 after drifting below its 10- and 20-day averages. Momentum has been bearish, but not broken, with RSI near 47 and price still above the 50-day SMA. The more interesting angle is positioning: short interest has risen into year-end and the stock’s OTC liquidity can turn that into sharp, fast moves. This trade idea looks…
Alaska Air Group (ALK) is pushing above key moving averages as airline fundamentals improve into 2026. With limited capacity growth, resilient premium demand, and a fleet modernization/expansion narrative gaining oxygen, the market is starting to re-rate the stock. This is a mid-term long trade built around momentum plus improving earnings expectat…
Rolls-Royce (RYCEY) is consolidating just below its $17.76 52-week high with price holding above key moving averages and RSI in a healthy, not-euphoric zone. With a $145B market cap, a ~19x P/E, and visible catalysts across aerospace aftermarket, defense, and nuclear optionality, the tape is offering a high-probability continuation setup. This trad…
Aeluma (ALMU) has pulled back sharply from recent averages, leaving a technically washed-out chart and a fundamental backdrop that is arguably better than the price action suggests. With a strong balance sheet for its size, rising short interest, and multiple visibility-building catalysts on the calendar, the risk-reward favors a defined-risk long …
Honda’s ADR is back near $30 after fading from its 52-week high, but the news flow has quietly improved. Sony Honda Mobility is moving from concept hype to trial production in Ohio, with deliveries planned in California in 2026. Meanwhile, HMC still trades at roughly 10x earnings and under 0.5x book, with a ~3.75% dividend yield. The chart is not p…
Agilysys (AGYS) is down hard, fast: roughly -23% from the prior close and now sitting around $90.86 after tagging $87.64 intraday on extreme volume. This kind of air pocket is exactly where good software names can hand you a high-quality entry - if you’re disciplined about risk. With RSI near 26 (deeply oversold), no balance-sheet leverage (debt-to…
Ubisoft’s ADR is trading under $1 with a sub-$700M market cap and a price-to-book below 0.4. That is the market’s way of saying the turnaround is over before it starts. But the mix of deeply washed-out technicals, a still-relevant portfolio of franchises, and real strategic-option value makes this look more like deep value than a classic value trap…
enGene is a clinical-stage gene therapy company with a sharp recent re-rating and a chart pushing into fresh 52-week highs. With the stock still below its prior spike highs and short interest rising into year-end, this sets up as a mid-term catalyst trade into the back half of 2026. The plan is simple: buy strength near support, define risk below t…
MercadoLibre has already started to bounce off its 2025 lows, but the setup still looks like a quality growth leader trading below what its fundamentals justify. With strong technical momentum, a reasonable valuation for the business quality, and clear upside back toward prior highs, this trade targets a mid-term push higher with defined risk under…
